Primary Site >> Pancreatic Cancer
Gene >> TGFB2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. PMID: 8760600 |
Ref: Biologic instability of pancreatic cancer xenografts in the nude mouse. PMID: 10836999 Ref: Retinoic acid-dependent transforming growth factor-beta 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway. PMID: 10938282 |
Ref: Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. PMID: 11408925 |
Ref: Transforming growth factor-beta 2 is a transcriptional target for Akt/protein kinase B via forkhead transcription factor. PMID: 12011061 |
Ref: Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. PMID: 15289325 |
Ref: Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. PMID: 16094523 Ref: Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009. PMID: 16377233 Ref: MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications. PMID: 17032197 |
Ref: Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. PMID: 17804750 Ref: On the role of transforming growth factor-beta in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells. PMID: 18157915 |
Ref: Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors. PMID: 18084956 |
Ref: Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. PMID: 21366804 Ref: The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-beta2. PMID: 21619536 |
Ref: Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress? PMID: 22797389 Ref: Development of a unique mouse model for pancreatic cancer lymphatic metastasis. PMID: 22941445 |
Ref: Vasohibin-1 expression is regulated by transforming growth factor-beta/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells. PMID: 23651239 |
Ref: HOXA10 promotes cell invasion and MMP-3 expression via TGFbeta2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells. PMID: 24464212 Ref: Biomarkers of TGF-beta signaling pathway and prognosis of pancreatic cancer. PMID: 24465802 |
Ref: Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer. PMID: 26279302 Ref: Paracrine tumor signaling induces transdifferentiation of surrounding fibroblasts. PMID: 26467073 |
Ref: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-beta2/TGF-betaRIII signalings. PMID: 29433538 |